Why heart disease mortality is low in France: the time lag explanation
- Malcolm Law, reader (M.R.Law@mds.qmw.ac.uk),
- Nicholas Wald, professor
- Wolfson Institute of Preventive Medicine, St Bartholomew's and The Royal London School of Medicine and Dentistry, London EC1M 6BQ
- aChanning Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston MA, 02115, USA
- bDepartments of Epidemiology and Nutrition, Harvard School of Public Health, Boston MA, 02115, USA
- MRC Environmental Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD
- Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands
- Correspondence to: Dr Law
In France mortality from ischaemic heart disease is about a quarter of that in Britain.1–7 The major risk factors are no more favourable in France, and this so called “French paradox” has not been satisfactorily explained. Table 1 shows the difference in mortality from heart disease between the countries, and table 2 shows the similar levels of animal fat consumption, serum total cholesterol and high density lipoprotein cholesterol concentrations, blood pressure, and (in men) smoking. The French paradox is usually attributed to the higher consumption of alcohol in France, notably of wine,2–5 and some have suggested a specific effect of red wine. In this article we assess quantitatively the extent to which this and other possible explanations can account for the low rate of heart disease in France. We then consider a novel “time lag” hypothesis, which, we believe, is the main explanation for the paradox.
Summary points
Mortality from ischaemic heart disease in France is about a quarter of that in Britain, but the major risk factors are similar
Undercertification of ischaemic heart disease in France could account for about 20% of the difference
The high consumption of alcohol in France, and of red wine inparticular, explains little of the difference
We propose that the difference is due to the time lag between increases in consumption of animal fat and serum cholesterol concentrations and the resulting increase in mortality from heart disease—similar to the recognised time lag between smoking and lung cancer. Consumption of animal fat and serum cholesterol concentrations increased only recently in France but did so decades ago in Britain
Evidence supports this explanation: mortality from heart disease across countries, including France, correlates strongly with levels of animal fat consumption and serum cholesterol in the past (30 years ago) but only weakly to …
Correspondence to: Dr Stampfer
Correspondence to: Professor Mackenbach
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012